Big Data Development Engineer Life Science 
Roots Analysis
JANUARY 28, 2024
Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of big data in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.
Drug Discovery World
JULY 18, 2022
Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? I love innovation and working with incredible minds in the pharmaceutical and life science fields who create amazing new technologies and methods of treatment,” says Groetken. His advice?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
JULY 11, 2023
Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?
pharmaphorum
FEBRUARY 1, 2022
David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. He is also a research fellow of the Royal Academy of Engineering and a fellow of the Alan Turing Institute. Since 2008, he has translated his work into the biomedical context for healthcare applications.
Drug Discovery World
DECEMBER 20, 2022
As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. They also expect that decentralised, adaptive and digitalised clinical trials will provide the opportunity to collect data more widely and efficiently next year. .
XTalks
APRIL 5, 2021
Since the conclusion of the project in 2003, bioinformatics tools have been used to identify genes and elucidate their function with the aim of developing gene-based strategies for disease prevention, diagnosis and treatment. This job furthers the field of biomedical research and supports drug development.
XTalks
MAY 9, 2024
We also invented four proprietary antibody technologies, including our DuoBody® bispecific technology which is the backbone of four FDA-approved bispecifics and over ten in development. What factors do you attribute to the company’s success in the discovery and development of differentiated antibody therapeutics?
Expert insights. Personalized for you.
40 
Let's personalize your content